Table 1b.
Characteristics of the 206 Patients from Institution 2, broken out into “poor” (discharged to acute care or death) and “good” (discharged to home or rehab) outcomes. Footnotes are provided by variable names to indicate significant differences in medians between groups at an α level of .05 using Mood’s median test using the “RVAideMemoire” package in R33.
| “Poor” Outcome N = 105 |
“Good” Outcome N = 101 |
||
|---|---|---|---|
| Variable | Details | N (%) or Median [IQR] | |
| Age, years | Continuous | 62 [54 – 80] | 59 [51 – 69] |
| Gender | Categorical | ||
| Male | 63 (60) | 58 (57.4) | |
| Female | 42 (40) | 43 (42.6) | |
| Race | Categorical | ||
| White | 60 (57.1) | 38 (37.6) | |
| Black or African American | 44 (41.9) | 61 (60.4) | |
| Asian | 1 (1.0) | 1 (1.0) | |
| Hispanic | 0 (0) | 1 (1.0) | |
| ICH Score, Total | Ordinal | ||
| 0 | 12 (11.4) | 38 (37.6) | |
| 1 | 20 (19) | 38 (37.6) | |
| 2 | 31 (29.5) | 19 (18.8) | |
| 3 | 34 (32.4) | 5 (5) | |
| >=4 | 8 (7.7) | 1 (1) | |
| Glasgow Coma Scale | Ordinal | ||
| 13–15 | 49 (46.7) | 83 (82.2) | |
| 5–12 | 6 (5.7) | 6 (5.9) | |
| 3–4 | 50 (47.6) | 12 (11.9) | |
| Intraventricular Hemorrhage | Categorical | ||
| Yes | 54 (51.4) | 27 (26.7) | |
| No | 51 (48.6) | 74 (73.3) | |
| Large Hematoma Volume | Categorical | ||
| At least 30 mL | 42 (40) | 15 (14.9) | |
| Less than 30 mL | 63 (60) | 86 (85.1) | |
| Initial Hematoma Volume, mL4 | Continuous | 22 [6 – 47] | 8 [4 – 19] |
| Hematoma Location | Categorical | ||
| Infratentorial | 21 (20) | 18 (17.8) | |
| Supratentorial | 84 (80) | 83 (82.2) | |
| Hematoma Expansion | Categorical | ||
| Presence | 18 (17.1) | 8 (7.9) | |
| Absence | 87 (82.9) | 93 (92.1) | |
| Seizure | Categorical | ||
| Has had a seizure | 15 (14.3) | 6 (5.7) | |
| Has not had a seizure | 90 (85.7) | 95 (90.5) | |
| Warfarin or Novel Oral Anticoagulant | Categorical | ||
| Given | 11 (10.5) | 8 (7.9) | |
| Not given | 94 (89.5) | 93 (92.1) | |
| International Normalized Ratio | Continuous | 1.1 [1 – 1.2] | 1.1 [1 – 1.1] |
| Statin | Categorical | ||
| Usage | 26 (24.8) | 25 (24.8) | |
| No usage | 79 (75.2) | 76 (75.2) | |
| Aspirin Use Prior to ICH | Categorical | ||
| Usage | 36 (34.3) | 37 (36.6) | |
| No usage | 69 (65.7) | 64 (63.4) | |
| Diabetes by history | Categorical | ||
| Diagnosis | 30 (28.6) | 12 (11.9) | |
| No diagnosis | 75 (71.4) | 89 (88.1) | |
| Hypertension by history | Categorical | ||
| Diagnosis | 86 (81.9) | 82 (81.2) | |
| No diagnosis | 19 (18.1) | 19 (18.8) | |
4
χ2 (1, 206) = 15.23 , p < .001